Skip to content

The Effectiveness of Buccal Infiltration Only Using Articaine for Extraction of Mandibular Molar

The Effectiveness of Buccal Infiltration Only Using Articaine for Routine Exodontia of Mandibular Molar: A Cross-Over Randomized Controlled Clinical Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06161714
Enrollment
40
Registered
2023-12-08
Start date
2023-11-30
Completion date
2024-04-30
Last updated
2023-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Brief summary

The goal of this clinical trial, is to test out the efficacy of using Articaine only as a local anesthesia as buccal infiltration to extract lower molar teeth. Study will be performed in patients visiting Riyadh Elm University clinics seeking extraction of lower molars bilaterally, in each visit one molar tooth will be extracted using Ariticaine and the second visit with Lidocaine, pain level will be monitored and documented. This study may be helpful in providing scientific information to the oral maxillofacial surgeons which will assist them in choosing the best local anesthetic agent, and possibly substituting using inferior alveolar nerve block with infiltration only when extracting the mandibular posterior teeth.

Detailed description

This is a double-blind, randomized clinical trial, which will involve 40 patients visiting the out-patient department of Oral and Maxillofacial surgery. For each patient, one mandibular molar will be extracted from right as well as left side, with one side being anesthetized using 4% articaine with 1:100,000 epinephrine and other with 2% lidocaine with 1:100,000 epinephrine buccal infiltration only. Evaluation and comparison will be done on the basis of pain prevalence exhibited by the patients while extraction.

Interventions

4% articaine with 1:100,000 epinephrine buccal infiltration

DRUGLidocaine 2%/Epi 1:100000 Inj Cart 1.7Ml

2% Lidocaine with 1:100,000 epinephrine buccal infiltration

Sponsors

Riyadh Elm University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

This is a double blinded randomized clinical trial, which neither the injector (investigator) nor the participant will know what anesthesia type was used in each session.

Intervention model description

One 1.8 ml cartridge of 4% articaine with 1:100,000 epinephrine will be utilized in the articaine group and one 1.8 ml cartridge of 2% lidocaine with 1:100,000 epinephrine will be utilized in the lidocaine group. The cartridges will be of similar size and shape, to be allotted a special code, enclosed in thin, adhesive tape by the distributor, and kept into one box for articaine and another box for lidocaine. A 27-gauge needle will be used for buccal infiltration in each case. Any sensation of pain after administering the local anesthesia will be considered as a failure and an inferior alveolar nerve block will be given. Otherwise, the tooth will be extracted with no additional anesthesia.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male and female patients * Patients with age more than 18 years * Patients indicated for at least one mandibular molar extraction * Patients with the ability to fill the questionnaire

Exclusion criteria

* Patients with abscess or any lesion, which may affect the local anesthesia provision. * Patients with stage III mobile teeth * Patients with a history of medical conditions such as diabetes mellitus, heart disease, pregnancy, allergy or renal disease * Patients who are not able to give an informed consent or are not agreeing to take part in this study

Design outcomes

Primary

MeasureTime frameDescription
Pain measurementPain will be measured after injection, during extraction procedure and at the end of the session immediately after finishing the procedure, scale of pain will be 0 for no pain and 10 for maximum painPain will be measured using the vial analogue scale

Contacts

Primary ContactAlbatool Baroom
Albatool.a.baroom2021@student.riyadh.edu.sa+966562600600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026